Envision Accelerate US 2025
Together, let's continue to shine a light on what's possible and accelerate our impact.
For over two decades, Envision Pharma Group has led the industry with medical communications, creative strategies, and technical solutions that help garner support and efficiencies for a more targeted organizational medical strategy. This year, we are thrilled to host the return of Envision Accelerate US! Check out our agenda, which includes fresh topics and relevant industry intel. Don’t miss the exclusive demo of EnvisionOne!
Don’t miss out on a mix of impactful sessions:
- Embrace the future of technology! Amplify your medical affairs strategy with the EnvisionOne platform
- Tools and technology for today and tomorrow: Spotlight new technology via demonstrations of our newest solutions on EnvisionOne (including a sneak preview of Datavision)
- Next-level external customer experience: Explore concepts to enhance customer interactions and satisfaction
- Maximize your investment by leveraging data, AI, and services for the win! Turn your investment in tools and technology into engagement and action
- Adopt our evolving medical strategy for the future: The future of medical affairs lies in empowering organizations to optimize investments in data-driven, patient-centric approaches

Max will explore how breakthrough technologies like gene therapy, AI-driven drug development, and bespoke medicines are reshaping the healthcare landscape. But with every tailwind comes a headwind. He'll tackle the delicate balance between innovation speed and patient safety – and why public policy has never been more important (or more complicated). From AI-designed experiments to the evolving role of the FDA, this session should challenge us to think about how industry can move fast, and responsibly.
Here's what a 2024 Envision Accelerate attendee said about our meeting:
“I was excited to hear industry leaders address the challenges of leveraging data, and the innovative ways EnvisionOne will provide comprehensive solutions to tailor our needs.”